MKT Pharma · International partnerships
Vietnam's gateway for international medicine partnerships
We partner with global manufacturers to bring trusted medicines to Vietnam through the country’s largest hospital distribution network — with regulatory experts who know the path.
New · Q4 2025 market intelligence
Vietnam’s pharma market reached ~USD 9bn
Our Q4 2025 report breaks the market down by channel, therapy class, and the top corporations — sourced from IQVIA, BMI Fitch, and WHO. A concise read on where the growth is concentrated.
Read the Market Report →Why Vinapharma
1,000+ hospitals, 5,000+ pharmacies
Direct relationships with K Hospital, Cho Ray, HCMC Oncology, Bach Mai, and the top tertiary centers across Vietnam — converting tender wins into shelf placement faster than any new entrant.
DAV regulatory expertise
A dedicated regulatory affairs team with active relationships at Vietnam's Drug Administration. We compress dossier timelines that take competitors 24–36 months.
20-headcount oncology bench
A specialty force at Vietnam's oncology centers — proven launches in TKIs, biosimilars, and cytotoxics with originator and generic partners alike.
Looking for a Vietnam distribution partner?
We work with originators, EU-GMP generics, and WHO-GMP suppliers. Tell us your molecule — we’ll send a 2-page Vietnam Market Entry Brief specific to it.
Request a market entry brief